S. Ramanathan

4.0k citations

116 papers · 3.2k indexed · 1 hit paper · h-index 34

Impact in

Virology top 1%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Ceramics and Composites 23
- Advanced ceramic materials synthesis 17
Virology 12
- HIV Research and Treatment 12

Co-authors: Arumugam Veera Ravi (19 shared papers)Arunachalam Kannappan (18 shared papers)Brian P. Kearney (16 shared papers)Shunmugiah Karutha Pandian (13 shared papers)Xiangmin Lin (13 shared papers)Sivasubramanian Santhakumari (5 shared papers)Sujit Roy (15 shared papers)Andrew Cheng (8 shared papers)
Journals: JAIDS Journal of Acquired Immune Deficiency Syndromes (6 papers)Journal of Alloys and Compounds (6 papers)Frontiers in Microbiology (5 papers)The Journal of Clinical Pharmacology (4 papers)Ceramics International (4 papers)
Partner nations: India United States China

In The Last Decade

S. Ramanathan

114 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

Bacterial Biofilm Inhibition: A Focused Review on Recent Therapeutic Strategies for Combating the Biofilm Mediated Infections 2021 · 221 citations

Peers

Countries citing papers authored by S. Ramanathan

Since Specialization

Citations

This map shows the geographic impact of S. Ramanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ramanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ramanathan more than expected).

Fields of papers citing papers by S. Ramanathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Ramanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ramanathan. The network helps show where S. Ramanathan may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Ramanathan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Ramanathan Line = papers co-authored together S. Ramanathan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial The Lancet ·Edwin DeJesus, Jürgen K. Rockstroh, Keith Henry, Jean‐Michel Molina, Joseph Gathe, S. Ramanathan, Xuelian Wei, Kitty Yale, Javier Szwarcberg, Kirsten White, Andrew Cheng, Brian P. Kearney	2012	256
2	Bacterial Biofilm Inhibition: A Focused Review on Recent Therapeutic Strategies for Combating the Biofilm Mediated Infections Frontiers in Microbiology ·S. Ramanathan, Sivasubramanian Santhakumari, Pandurangan Poonguzhali, Mani Geetha, Madhu Dyavaiah, Xiangmin Lin Hit paper breakdown →	2021	221
3	Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir Clinical Pharmacokinetics ·S. Ramanathan, Anita Mathias, Polina German, Brian P. Kearney	2011	127
4	A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and Tenofovir DF for Initial Treatment of HIV-1 Infection JAIDS Journal of Acquired Immune Deficiency Syndromes ·Jürgen K. Rockstroh, Edwin DeJesus, Keith Henry, Jean‐Michel Molina, Joseph Gathe, S. Ramanathan, Xuelian Wei, Andrew Plummer, Michael E. Abram, Andrew Cheng, Marshall W. Fordyce, Javier Szwarcberg	2013	97
5	Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection AIDS ·Calvin Cohen, Richard Elion, Peter Ruane, David Shamblaw, Edwin DeJesus, Bruce Rashbaum, Steven L. Chuck, Kitty Yale, Hui C. Liu, David R. Warren, S. Ramanathan, Brian P. Kearney	2011	93
6	Piper betle and its bioactive metabolite phytol mitigates quorum sensing mediated virulence factors and biofilm of nosocomial pathogen Serratia marcescens in vitro Journal of Ethnopharmacology ·S. Ramanathan, Kannan Rama Devi, Arunachalam Kannappan, Shunmugiah Karutha Pandian, Arumugam Veera Ravi	2016	84
7	Marine Bacterial Secondary Metabolites: A Treasure House for Structurally Unique and Effective Antimicrobial Compounds Marine Drugs ·S. Ramanathan, Arunachalam Kannappan, Chunlei Shi, Xiangmin Lin	2021	81
8	Antibiofilm activity of Vetiveria zizanioides root extract against methicillin-resistant Staphylococcus aureus Microbial Pathogenesis ·Arunachalam Kannappan, Shanmugaraj Gowrishankar, S. Ramanathan, Shunmugiah Karutha Pandian, Arumugam Veera Ravi	2017	68
9	Exploring the Anti-quorum Sensing and Antibiofilm Efficacy of Phytol against Serratia marcescens Associated Acute Pyelonephritis Infection in Wistar Rats Frontiers in Cellular and Infection Microbiology ·S. Ramanathan, Mohankumar Ramar, Arunachalam Kannappan, Veeramani Karthick Raja, Govindaraju Archunan, Shunmugiah Karutha Pandian, Ruckmani Kandasamy, Arumugam Veera Ravi	2017	65
10	Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib Clinical Pharmacokinetics ·S. Ramanathan, Feng Jin, Shringi Sharma, Brian P. Kearney	2015	63
11	Inhibition of quorum sensing-dependent biofilm and virulence genes expression in environmental pathogen Serratia marcescens by petroselinic acid Antonie van Leeuwenhoek ·S. Ramanathan, Ravindran Durgadevi, Arunachalam Kannappan, Arumugam Veera Ravi	2017	63
12	Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment Antimicrobial Agents and Chemotherapy ·Joseph M. Custodio, Marshall W. Fordyce, William Garner, Mona Vimal, Kah Hiing John Ling, Brian P. Kearney, S. Ramanathan	2016	62
13	In vitro and in vivo efficacy of rosmarinic acid on quorum sensing mediated biofilm formation and virulence factor production inAeromonas hydrophila Biofouling ·Kannan Rama Devi, S. Ramanathan, Arunachalam Kannappan, Sivasubramanian Santhakumari, B. Murugan, Periyannan Rajasekar, Narayanan Marimuthu Prabhu, Arumugam Veera Ravi	2016	59
14	Phytosynthesized silver nanoparticles as antiquorum sensing and antibiofilm agent against the nosocomial pathogenSerratia marcescens: anin vitrostudy Journal of Applied Microbiology ·Ravindran Durgadevi, S. Ramanathan, Arunachalam Kannappan, Godfred Ponraj Jeyaraj, Shunmugiah Karutha Pandian, Arumugam Veera Ravi	2018	58
15	Processing and characterization of combustion synthesized YAG powders Ceramics International ·S. Ramanathan, M. B. Kakade, Sujit Roy, K. K. Kutty	2003	57
16	Biogenic synthesis of silver nanoparticles using Piper betle aqueous extract and evaluation of its anti-quorum sensing and antibiofilm potential against uropathogens with cytotoxic effects: an in vitro and in vivo approach Environmental Science and Pollution Research ·S. Ramanathan, Loganathan Vigneshwari, Tamilselvam Rajavel, Ravindran Durgadevi, Arunachalam Kannappan, Krishnaswamy Balamurugan, Kasi Pandima Devi, Arumugam Veera Ravi	2017	54
17	Pharmacokinetics of Emtricitabine, Tenofovir, and GS-9137 Following Coadministration of Emtricitabine/Tenofovir Disoproxil Fumarate and Ritonavir-Boosted GS-9137 JAIDS Journal of Acquired Immune Deficiency Syndromes ·S. Ramanathan, Gong Shen, Andrew Cheng, Brian P. Kearney	2007	54
18	Alumina powders from aluminium nitrate-urea and aluminium sulphate-urea reactions — The role of the precursor anion and process conditions on characteristics Ceramics International ·S. Ramanathan, Sujit Roy, R. Bhat, D. D. Upadhyaya, Aniruddha Biswas	1997	54
19	Effect of heat treatment on pore structure in nano-crystalline NiO: A small angle neutron scattering study Journal of Solid State Chemistry ·Jitendra Bahadur, Debasis Sen, S. Mazumder, S. Ramanathan	2008	50
20	Targeting the Sodium-Dependent Multivitamin Transporter (SMVT) for Improving the Oral Absorption Properties of a Retro-Inverso Tat Nonapeptide Pharmaceutical Research ·S. Ramanathan, Shahriar Pooyan, Stanley J. Stein, Puttur D. Prasad, Jihong Wang, Michael J. Leibowitz, Vadivel Ganapathy, Patrick J. Sinko	2001	48

About S. Ramanathan

S. Ramanathan is a scholar working on Ceramics and Composites, Virology, Infectious Diseases, Molecular Medicine and Endocrinology, having authored 116 papers that have together received 3.2k indexed citations. Recurring topics across this work include Bacterial biofilms and quorum sensing (19 papers), HIV/AIDS drug development and treatment (18 papers), Advanced ceramic materials synthesis (17 papers), HIV Research and Treatment (12 papers), Aquaculture disease management and microbiota (12 papers), Nuclear materials and radiation effects (8 papers), Advancements in Solid Oxide Fuel Cells (8 papers) and Luminescence Properties of Advanced Materials (7 papers). The work is most often cited by research in Virology (584 citations), Infectious Diseases (950 citations), Molecular Medicine (194 citations), Ceramics and Composites (214 citations) and Microbiology (226 citations). S. Ramanathan has collaborated with scholars based in India, United States and China. Frequent co-authors include Arumugam Veera Ravi, Arunachalam Kannappan, Brian P. Kearney, Shunmugiah Karutha Pandian, Xiangmin Lin, Sivasubramanian Santhakumari, Sujit Roy, Andrew Cheng, Ravindran Durgadevi and Edwin DeJesus. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of Alloys and Compounds, Frontiers in Microbiology, The Journal of Clinical Pharmacology and Ceramics International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact